Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Decibel Cannabis CoTSXV:DB +4.76%41 Debt-to-Equity is 0.96 as of Mar. 2026, which is 2% below its 10-year median of 0.98. GuruFocus rates TSXV:DB with a GF Score™ of 41/100 and a GF Value™ of C$0.11 (Fairly Valued). The stock has 6 warning signs investors should review. Among 813 Drug Manufacturers companies, Decibel Cannabis Co ranks worse than 83.64% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Decibel Cannabis Co's Debt-to-Equity or its related term are showing as below:
TSXV:DB'
s Debt-to-Equity Range Over the Past 10 Years
Min: -0.38 Med: 0.98 Max: 1.4
Current: 0.96
During the past 13 years, the highest Debt-to-Equity Ratio of Decibel Cannabis Co was 1.40. The lowest was -0.38. And the median was 0.98.
TSXV:DB's Debt-to-Equity is ranked worse than 83.64% of 813
companies
in the Drug Manufacturers industry
Industry Median: 0.27
vs TSXV:DB: 0.96
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Decibel Cannabis Co Debt-to-Equity Related Terms
Decibel Cannabis Co Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Decibel Cannabis Co's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Decibel Cannabis Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Decibel Cannabis Co Debt-to-Equity vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Decibel Cannabis Co's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Decibel Cannabis Co's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Decibel Cannabis Co (TSXV:DB) has a Debt-to-Equity of 0.96 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Decibel Cannabis Co and its competitors. This is near median its historical median of 0.98. According to the industry distribution chart, Decibel Cannabis Co ranks #680 out of 813 companies in the Drug Manufacturers industry, placing it in the top 83.6%.
Is Decibel Cannabis Co's Debt-to-Equity too high?
Decibel Cannabis Co's current Debt-to-Equity of 0.96 is near median its 10-year median of 0.98. The Drug Manufacturers industry median Debt-to-Equity is 0.27. Decibel Cannabis Co's value of 0.96 is 255.6% above this industry median. Based on the distribution chart, Decibel Cannabis Co ranks #680 out of 813 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Decibel Cannabis Co has a GF Score™ of 41/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Decibel Cannabis Co's Debt-to-Equity compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Decibel Cannabis Co ranks #680 out of 813 companies for Debt-to-Equity. This places Decibel Cannabis Co in the lower half of its industry. The industry median Debt-to-Equity is 0.27. Decibel Cannabis Co's value of 0.96 is 255.6% above this benchmark. While the company's 10-year median is 0.98 vs. the industry median of 0.27, Decibel Cannabis Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Drug Manufacturers company?
The median Debt-to-Equity among Drug Manufacturers companies is 0.27, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Decibel Cannabis Co's current Debt-to-Equity of 0.96 is 255.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Decibel Cannabis Co and its competitors. For the Drug Manufacturers industry, the median Debt-to-Equity is 0.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Decibel Cannabis Co's current Debt-to-Equity is 0.96, which is near median its own 10-year median of 0.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Decibel Cannabis Co stock overvalued right now?
Based on GuruFocus' analysis, Decibel Cannabis Co (TSXV:DB) is currently considered Fairly Valued. The stock's GF Value™ is C$0.11, compared to a current price of C$0.11 — trading right at its estimated fair value. The current Debt-to-Equity is 0.96, which is near median its 10-year median of 0.98 and 255.6% above the Drug Manufacturers industry median of 0.27. Decibel Cannabis Co's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Decibel Cannabis Co (TSXV:DB), the current Debt-to-Equity is 0.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Decibel Cannabis Co (TSXV:DB) Overvalued in 2026?
Based on GuruFocus' analysis, Decibel Cannabis Co stock appears to be undervalued.
The current stock price of C$0.11 is trading 0% below its estimated GF Value™ of C$0.11.
GuruFocus considers Decibel Cannabis Co to be Fairly Valued.
Key valuation signals for TSXV:DB:
Debt-to-Equity: 0.96 (near median its 10-year median of 0.98)
GF Value™: C$0.11 vs. price of C$0.11 (0% below fair value)
Industry Position: 255.6% above the Drug Manufacturers median (#680 of 813)
No single metric tells the full story. See the TSXV:DB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Decibel Cannabis Co Inc is engaged in the cannabis operations business. The company is involved in the production, distribution, and sale of recreational cannabis. All the revenues are generated in Canada. The company's revenue is comprised of wholesale sales of both products and services through its production facilities to distributors and licensed cannabis producers and the direct sale of products through its retailer locations to end customers.
41GF Score
Get the complete analysis for TSXV:DB
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:DB has been successfully added to your 
